

Imuran is a prescription drug that can prevent kidney transplant rejection and treat rheumatoid arthritis. This eMedTV page offers an overview of Imuran, providing information on how the medicine works, potential side effects, and dosing guidelines.
Common Imuran side effects include nausea, low levels of white blood cells, and infections. This page of the eMedTV Web site provides a list of common and rare side effects of Imuran, as well as side effects that may require medical attention.
Imuran has been approved for preventing a kidney transplant rejection and treating rheumatoid arthritis. This eMedTV article discusses these uses in more detail and also outlines some off-label Imuran uses, such as treating ulcerative colitis.
The starting Imuran dose for preventing rejection of a kidney transplant is 3 mg to 5 mg per kg once a day. This eMedTV page explains factors that may affect your Imuran dosage and also provides dosing information when treating rheumatoid arthritis.
As this eMedTV segment explains, Imuran drug interactions can occur when you combine it with medications such as ACE inhibitors, warfarin, or other drugs. This article also describes the steps your doctor may take to avoid these drug interactions.
Imuran can increase your risk of certain types of cancer and can interfere with your immune system. This eMedTV page takes an in-depth look at other important Imuran warnings and precautions, including a list of those who should not take the drug.
This portion of the eMedTV archives examines possible symptoms of an Imuran overdose. It also explains some of the treatment options your healthcare provider may use to remove the medication from your body and relieve symptoms.
Studies on Imuran and pregnancy have demonstrated that there is a risk to the fetus. This eMedTV resource describes the results of these studies in more detail and explains why the FDA classifies Imuran as a pregnancy Category D medication.
This eMedTV page explains that because Imuran does pass through breast milk and may cause serious side effects (including cancer) to the nursing infant, the manufacturer of the drug does not recommend taking Imuran and breastfeeding at the same time.
Currently, generic Imuran is available under the names Azathioprine tablets and Azasan tablets. This eMedTV article lists the various strengths of generic Imuran that are available and explains why the FDA assigned the generic drug an "AB" rating.
| Referring Pages | Articles |